研究業績

英文学術論文

  1. Shigeru Fujita‡, Yusuke Kosugi‡, Izumi Kimura, Kenzo Tokunaga, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jumpei Ito & Kei Sato*. Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2. Journal of Virology in press. ‡Equal contribution; *Corresponding author.
  2. Shigeru Fujita, Keiya Uriu, Lin Pan, Naganori Nao, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hirofumi Sawa, Izumi Kida, Tomokazu Tamura, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Takasuke Fukuhara, Jumpei Ito, Keita Matsuno‡ & Kei Sato‡*. Impact of imprinted immunity induced by mRNA vaccination in an experimental animal model. Journal of Infectious Diseases in press. ‡Equal contribution; *Corresponding author.
  3. Tomokazu Tamura‡, Daichi Yamasoba‡, Yoshitaka Oda‡, Jumpei Ito‡, Tomoko Kamasaki‡, Naganori Nao‡, Rina Hashimoto, Yoichiro Fujioka, Rigel Suzuki, Lei Wang, Hayato Ito, Yukie Kashima, Izumi Kimura, Mai Kishimoto, Masumi Tsuda, Hirofumi Sawa , Kumiko Yoshimatsu, Yuki Yamamoto, Tetsuharu Nagamoto, Jun Kanamune, Yutaka Suzuki, Yusuke Ohba, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Isao Yokota*, Keita Matsuno*, Kazuo Takayama*, Shinya Tanaka*, Kei Sato* & Takasuke Fukuhara*. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5. Communications Biology in press. *Corresponding author.
  4. Yukio Watanabe‡, Izumi Kimura‡, Rina Hashimoto‡, Ayaka Sakamoto, Naoko Yasuhara, Takuya Yamamoto, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato* & Kazuo Takayama*. Virological characterization of the 2022 outbreak-causing monkeypox virus using human keratinocytes and colon organoids. Journal of Medical Virology 95:1-14, 2023. ‡Equal contribution; *Corresponding authors.
  5. Daichi Yamasoba‡, Keiya Uriu‡, Arnon Plianchaisuk1‡, Yusuke Kosugi‡, Lin Pan‡, Jiri Zahradnik, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jumpei Ito & Kei Sato*. Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant. Lancet Infectious Diseases 23(6):655-656, 2023. ‡Equal contribution; *Corresponding author.
  6. Tomokazu Tamura‡, Jumpei Ito‡, Keiya Uriu‡, Jiri Zahradnik‡, Izumi Kida‡, Yuki Anraku‡, Hesham Nasser‡, Maya Shofa‡, Yoshitaka Oda‡, Spyros Lytras‡, Naganori Nao, Yukari Itakura, Sayaka Deguchi, Rigel Suzuki, Lei Wang, MST Monira Begum, Shunsuke Kita, Hisano Yajima, Jiei Sasaki, Kaori Sasaki-Tabata, Ryo Shimizu, Masumi Tsuda, Yusuke Kosugi, Shigeru Fujita, Lin Pan, Daniel Sauter, Kumiko Yoshimatsu, Saori Suzuki, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Yuki Yamamoto, Tetsuharu Nagamoto, Gideon Schreiber, Katsumi Maenaka, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Takao Hashiguchi, Terumasa Ikeda, Takasuke Fukuhara, Akatsuki Saito, Shinya Tanaka*, Keita Matsuno*, Kazuo Takayama* & Kei Sato*. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nature Communications 14:2800, 2023. ‡Equal contribution; *Corresponding authors.
  7. Jumpei Ito‡, Rigel Suzuki‡, Keiya Uriu‡, Yukari Itakura‡, Jiri Zahradnik‡, Kanako Terakado Kimura‡, Sayaka Deguchi‡, Lei Wang‡, Spyros Lytras‡, Tomokazu Tamura, Izumi Kida, Hesham Nasser, Maya Shofa, MST Monira Begum, Masumi Tsuda, Yoshitaka Oda, Tateki Suzuki, Jiei Sasaki, Kaori Sasaki-Tabata, Shigeru Fujita, Kumiko Yoshimatsu, Hayato Ito, Naganori Nao, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Yuki Yamamoto, Tetsuharu Nagamoto, Jin Kuramochi, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Akatsuki Saito, Keita Matsuno, Kazuo Takayama, Takao Hashiguchi*, Shinya Tanaka*, Takasuke Fukuhara*, Terumasa Ikeda* & Kei Sato*. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant. Nature Communications 14:2671, 2023. ‡Equal contribution; *Corresponding authors.
  8. Shiho Torii‡, Kwang Su Kim‡, Jun Koseki‡, Rigel Suzuki‡, Shoya Iwanami, Yasuhisa Fujita, Yong Dam Jeong, Jumpei Ito, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato, Yoshiharu Matsuura*, Teppei Shimamura*, Shingo Iwami* & Takasuke Fukuhara*. Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir. PLOS Pathogens 19(3): e1011231, 2023. ‡Equal contribution.
  9. Keiya Uriu‡, Jumpei Ito‡, Jiri Zahradnik‡, Shigeru Fujita, Yusuke Kosugi, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium & Kei Sato*. Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant. Lancet Infectious Diseases23(3):280-281, 2023. ‡Equal contribution; *Corresponding author.
  10. Shigeru Fujita‡, Yusuke Kosugi‡, Izumi Kimura, Daichi Yamasoba, The Genotype to Phenotype Japan (G2P‐Japan) Consortium, & Kei Sato*. Structural Insight into the Resistance of the SARS‐CoV‐2 Omicron BA.4 and BA.5 Variants to Cilgavimab. Viruses 14(12):2677, 2022. ‡Equal contribution; *Corresponding author.
  11. Izumi Kimura‡, Daichi Yamasoba‡, Hesham Nasser‡, Jiri Zahradnik‡, Yusuke Kosugi‡, Jiaqi Wu‡, Kayoko Nagata, Keiya Uriu, Yuri L Tanaka, Jumpei Ito, Ryo Shimizu, Toong Seng Tan, Erika P Butlertanaka, Hiroyuki Asakura, Kenji Sadamasu, Kazuhisa Yoshimura, Takamasa Ueno, Akifumi Takaori-Kondo, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Mako Toyoda, Kotaro Shirakawa, Takashi Irie, Akatsuki Saito*, So Nakagawa*, Terumasa Ikeda* & Kei Sato*$. The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant. iScience 25(12):105720, 2022. ‡Equal contribution; *Corresponding authors; $Lead contact.
  12. Kayoko Nagata‡, Daichi Utsumi‡, Masamitsu N. Asaka‡, Ryota Maeda‡, Kotaro Shirakawa, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Yohei Yanagida, Yugo Kawai, Kei Sato, Yutaro Yamaoka, Kei Miyakawa, Akihide Ryo, Yasuhiro Yasutomi*, Akihiro Imura* & Akifumi Takaori-Kondo*. Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice. Communications Medicine 2(1):152, 2022. ‡Equal contribution.
  13. Akatsuki Saito‡, Tomokazu Tamura‡, Jiri Zahradnik‡, Sayaka Deguchi‡, Koshiro Tabata‡, Izumi Kimura‡, Jumpei Ito‡, Hesham Nasser, Mako Toyoda, Kayoko Nagata, Keiya Uriu, Yusuke Kosugi, Shigeru Fujita, Daichi Yamasoba, Maya Shofa, MST Monira Begum, Yoshitaka Oda, Rigel Suzuki, Hayato Ito, Naganori Nao, Lei Wang, Masumi Tsuda, Kumiko Yoshimatsu, Yuki Yamamoto, Tetsuharu Nagamoto, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Takamasa Ueno, Gideon Schreiber, Akifumi Takaori-Kondo, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kotaro Shirakawa, Hirofumi Sawa, Takashi Irie, Kazuo Takayama, Keita Matsuno, Shinya Tanaka*, Terumasa Ikeda*, Takasuke Fukuhara* & Kei Sato*$. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host & Microbe 30(11):1540-1555, 2022. ‡Equal contribution; *Corresponding authors; $Lead contact.
  14. Hesham Nasser, Ryo Shimizu, Jumpei Ito, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Akatsuki Saito, Kei Sato & Terumasa Ikeda*. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay. STAR Protocols 3(4):101773, 2022.
  15. Izumi Kimura‡, Daichi Yamasoba‡, Tomokazu Tamura‡, Naganori Nao‡, Tateki Suzuki‡, Yoshitaka Oda‡, Shuya Mitoma‡, Jumpei Ito‡, Hesham Nasser‡, Jiri Zahradnik‡, Keiya Uriu, Shigeru Fujita, Yusuke Kosugi, Lei Wang, Masumi Tsuda, Mai Kishimoto, Hayato Ito, Rigel Suzuki, Ryo Shimizu, MST Monira Begum, Kumiko Yoshimatsu, Kanako Terakado Kimura, Jiei Sasaki, Kaori Sasaki-Tabata, Yuki Yamamoto, Tetsuharu Nagamoto, Jun Kanamune, Kouji Kobiyama, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Kotaro Shirakawa, Akifumi Takaori-Kondo, Jin Kuramochi, Gideon Schreiber, Ken J Ishii, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Takao Hashiguchi*, Terumasa Ikeda*, Akatsuki Saito*, Takasuke Fukuhara*, Shinya Tanaka*, Keita Matsuno* & Kei Sato*$. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell 185(21):3992-4007, 2022. ‡Equal contribution; *Corresponding authors; $Lead contact.
  16. Ryota Maeda‡*, Junso Fujita‡, Yoshinobu Konishi, Yasuhiro Kazuma, Hiroyuki Yamazaki, Itsuki Anzai, Tokiko Watanabe, Keishi Yamaguchi, Kazuki Kasai, Kayoko Nagata, Yutaro Yamaoka, Kei Miyakawa, Akihide Ryo, Kotaro Shirakawa, Kei Sato, Fumiaki Makino, Yoshiharu Matsuura, Tsuyoshi Inoue, Akihiro Imura, Keiichi Namba* & Akifumi Takaori-Kondo*. A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron. Communications Biology 5(1):669, 2022.
  17. Daichi Yamasoba‡, Yusuke Kosugi‡, Izumi Kimura‡, Shigeru Fujita, Keiya Uriu, Jumpei Ito & Kei Sato*, The Genotype to Phenotype Japan (G2P-Japan) Consortium. Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies. Lancet Infectious Diseases 22(7):942-943, 2022. ‡Equal contribution; *Corresponding author.
  18. Luiz Carlos Junior Alcantara, Lucas Amenga-Etego, Robin Andersson, Moumita Bhaumik, Young Ki Choi, Hélène Decaluwe, Jemma Geoghegan, Bart L. Haagmans, Susana López, Maowia M. Mukhtar, Erni Nelwan, Elias A. Rahal, Kei Sato, Ella H. Sklan & Yvonne Su Chuan Fang. Methods for fighting emerging pathogens. Nature Methods 19(4):395-397, 2022.
  19. Jumpei Ito, Yasunari Seita, Shohei Kojima, Nicholas F. Parrish, Kotaro Sasaki* & Kei Sato*. A hominoid-specific endogenous retrovirus may have rewired the gene regulatory network shared between primordial germ cells and naïve pluripotent cells. PLOS Genetics 18(5):e1009846, 2022. *Corresponding authors.
  20. Daichi Yamasoba‡, Izumi Kimura‡, Hesham Nasser‡, Yuhei Morioka‡, Naganori Nao‡, Jumpei Ito‡, Keiya Uriu‡, Masumi Tsuda‡, Jiri Zahradnik‡, Kotaro Shirakawa, Rigel Suzuki, Mai Kishimoto, Yusuke Kosugi, Kouji Kobiyama, Teppei Hara, Mako Toyoda, Yuri L Tanaka, Erika P Butlertanaka, Ryo Shimizu, Hayato Ito, Lei Wang, Yoshitaka Oda, Yasuko Orba, Michihito Sasaki, Kayoko Nagata, Kumiko Yoshimatsu, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Jin Kuramochi, Motoaki Seki, Ryoji Fujiki, Atsushi Kaneda, Tadanaga Shimada, Taka-aki Nakada, Seiichiro Sakao, Takuji Suzuki, Takamasa Ueno, Akifumi Takaori-Kondo, Ken J Ishii, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Hirofumi Sawa, Akatsuki Saito*, Takashi Irie*, Shinya Tanaka*, Keita Matsuno*, Takasuke Fukuhara*, Terumasa Ikeda* & Kei Sato*$. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell 185(12):2103-2115, 2022. ‡Equal contribution; *Corresponding authors; $Lead contact.
  21. Ryuichi Kumata‡, Shoya Iwanami‡, Katrina B. Mar, Yusuke Kakizoe, Naoko Misawa, Shinji Nakaoka, Yoshio Koyanagi, Alan S. Perelson, John W. Schoggins, Shingo Iwami* & Kei Sato*. Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection. PLOS Computational Biology 18(4):e1010053, 2022. ‡Equal contribution; *Corresponding authors.
  22. Keiya Uriu‡, Paúl Cárdenas‡, Erika Muñoz, Veronica Barragan, Yusuke Kosugi, Kotaro Shirakawa, Akifumi Takaori-Kondo, Ecuador-COVID19 Consortium, The Genotype to Phenotype Japan (G2P-Japan) Consortium & Kei Sato*. Characterization of the immune resistance of severe acute respiratory syndrome coronavirus 2 Mu variant and the robust immunity induced by Mu infection. Journal of Infectious Diseases 226(7):1200-1203, 2022. ‡Equal contribution; *Corresponding author.
  23. Rigel Suzuki‡, Daichi Yamasoba‡, Izumi Kimura‡, Lei Wang‡, Mai Kishimoto‡, Jumpei Ito‡, Yuhei Morioka, Naganori Nao, Hesham Nasser, Keiya Uriu, Yusuke Kosugi, Masumi Tsuda, Yasuko Orba, Michihito Sasaki, Ryo Shimizu, Ryoko Kawabata, Kumiko Yoshimatsu, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Hirofumi Sawa, Terumasa Ikeda, Takashi Irie, Keita Matsuno*, Shinya Tanaka*, Takasuke Fukuhara* & Kei Sato*. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603(7902):700-705, 2022. ‡Equal contribution; *Corresponding authors.
  24. Bo Meng‡, Adam Abdullahi‡, Isabella A. T. M. Ferreira‡, Niluka Goonawardane‡, Akatsuki Saito‡, Izumi Kimura‡, Daichi Yamasoba‡, Pehuén Pereyra Gerber, Saman Fatihi, Surabhi Rathore, Samantha K. Zepeda, Guido Papa, Steven A. Kemp, Terumasa Ikeda, Mako Toyoda, Toong Seng Tan, Jin Kuramochi, Shigeki Mitsunaga, Takamasa Ueno, Kotaro Shirakawa, Akifumi Takaori-Kondo, Teresa Brevini, Donna L. Mallery, Oscar J. Charles, The CITIID-NIHR BioResource COVID Collaboration, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Ecuador-COVID19 Consortium, John E. Bowen, Anshu Joshi, Alexandra C. Walls, Laurelle Jackson, Darren Martin, Kenneth G. C. Smith, John Bradley, John A. G. Briggs, Jinwook Choi, Elo Madissoon, Kerstin Meyer, Petra Mlcochova, Lourdes Ceron-Gutierrez, Rainer Doffinger, Sarah A. Teichmann, Andrew J. Fisher, Matteo S. Pizzuto, Anna de Marco, Davide Corti, Myra Hosmillo, Joo Hyeon Lee, Leo C. James, Lipi Thukral, David Veesler, Alex Sigal, Fotios Sampaziotis, Ian G. Goodfellow, Nicholas J. Matheson, Kei Sato* & Ravindra K. Gupta*. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603(7902):706-714, 2022. *Corresponding authors.
  25. Izumi Kimura‡, Yusuke Kosugi‡, Jiaqi Wu‡, Jiri Zahradnik, Daichi Yamasoba, Erika P. Butlertanaka, Yuri L. Tanaka, Keiya Uriu, Yafei Liu, Nanami Morizako, Kotaro Shirakawa, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Kenzo Tokunaga, Takamasa Ueno, Akifumi Takaori-Kondo, Gideon Schreiber, Hisashi Arase, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Chihiro Motozono, Akatsuki Saito, So Nakagawa* & Kei Sato*$. The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance. Cell Reports 38(2):110218, 2022. ‡Equal contribution; *Corresponding authors; $Lead contact.
  26. Kei Sato*. The true nature of viruses elucidated by Systems Virology. Frontiers in Virology 1: 808865, 2021. Review. *Corresponding author.
  27. Zhe Zhao, Riku Fagerlund, Helena Tossavainen, Kristina Hopfensperger, Rishikesh Lotke, Smitha Srinivasachar Badarinarayan, Frank Kirchhoff, Perttu Permi, Kei Sato, Daniel Sauter & Kalle Saksela*. Evolutionary plasticity of SH3 domain binding by Nef proteins of the HIV-1/SIVcpz lentiviral lineage. PLOS Pathogens 17(11):e1009728, 2021.
  28. Saito, A.‡, Irie, T.‡, Suzuki, R.‡, Maemura, T.‡, Nasser, H.‡, Uriu, K.‡, Kosugi, Y.‡, Shirakawa, K., Sadamasu, K., Kimura, I., Ito, J., Wu, J., Iwatsuki-Horimoto, K., Ito, M., Yamayoshi, S., Loeber, S., Tsuda, M., Wang, L., Ozono, S., Butlertanaka, E. P., Tanaka, Y. L., Shimizu, R., Shimizu, K., Yoshimatsu, K., Kawabata, R., Sakaguchi, T., Tokunaga, K., Yoshida, I., Asakura, H., Nagashima, M., Kazuma, Y., Nomura, R., Horisawa, Y., Yoshimura, K., Takaori-Kondo, A., Imai, M., The Genotype to Phenotype Japan (G2P-Japan) Consortium,Tanaka, S.*, Nakagawa, S.*, Ikeda, T.*, Fukuhara, T.*, Kawaoka, Y.* & Sato, K.* (2022) Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation, Nature. 602, 300-306,2022. ‡Equal contribution; *Corresponding authors.
  29. Keiya Uriu‡, Izumi Kimura‡, Kotaro Shirakawa, Akifumi Takaori-Kondo, Taka-aki Nakada, Atsushi Kaneda, So Nakagawa & Kei Sato*, The Genotype to Phenotype Japan (G2P-Japan) Consortium. Neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine serum. New England Journal of Medicine 385(25):2397-2399, 2021. ‡Equal contribution; *Corresponding author.
  30. Matteo Bosso, Christina M. Sturzel, Dorota Kmiec, Smitha Srinivasachar Badarinarayan, Elisabeth Braun, Jumpei Ito, Kei Sato, Beatrice H. Hahn, Konstantin M.J. Sparrer, Daniel Sauter & Frank Kirchhoff*. An additional NF-kB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins. Cell Reports 36(12):109735, 2021.
  31. Petra Mlcochova‡, Steven A. Kemp‡, Mahesh Shanker Dhar‡, Guido Papa, Bo Meng, Isabella A.T.M Ferreira, Rawlings Datir, Dami A. Collier, Anna Albecka, Sujeet Singh, Rajesh Pandey, Jonathan Brown, Jie Zhou, Niluka Goonawardane, Swapnil Mishra, Charles Whittaker, Thomas Mellan, Robin Marwal, Meena Datta, Shantanu Sengupta, Kalaiarasan Ponnusamy, Venkatraman Srinivasan Radhakrishnan, Adam Abdullahi, Oscar Charles, Partha Chattopadhyay, Priti Devi, Daniela Caputo, Tom Peacock, Chand Wattal, Neeraj Goel, Ambrish Satwik, Raju Vaishya, Meenakshi Agarwal, The Indian SARS-CoV-2 Genomics Consortium (INSACOG), The CITIID-NIHR BioResource COVID-19 Collaboration, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Antranik Mavousian, Joo Hyeon Lee, Jessica Bassi, Chiara Silacci-Fegni, Christian Saliba, Dora Pinto, Takashi Irie, Isao Yoshida, William L. Hamilton, Kei Sato, Samir Bhatt, Seth Flaxman, Leo C. James, Davide Corti, Luca Piccoli, Wendy S. Barclay, Partha Rakshit*, Anurag Agrawal* & Ravindra K. Gupta*. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599(7883):114-119, 2021. ‡Equal contribution.
  32. Caterina Prelli Bozzo‡, Rayhane Nchioua‡, Meta Volcic, Lennart Koepke, Jana Krüger, Desiree Schütz, Sandra Heller, Christina M. Stürzel, Dorota Kmiec, Carina Conzelmann, Janis Müller, Fabian Zech, Elisabeth Braun, Rüdiger Groß, Lukas Wettstein, Tatjana Weil, Johanna Weiß, Federica Diofano, Armando A. Rodríguez Alfonso, Sebastian Wiese, Daniel Sauter, Jan Münch, Christine Goffinet, Alberto Catanese, Michael Schön, Tobias M. Boeckers, Steffen Stenger, Kei Sato, Steffen Just, Alexander Kleger, Konstantin M. J. Sparrer* & Frank Kirchhoff*. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nature Communications 12(1):4584, 2021.
  33. Isabella A. T. M. Ferreira‡, Steven A. Kemp‡, Rawlings Datir, Akatsuki Saito, Bo Meng, Partha Rakshit, Akifumi Takaori-Kondo, Yusuke Kosugi, Keiya Uriu, Izumi Kimura, Kotaro Shirakawa, Adam Abdullahi, CITIID-NIHR BioResource COVID-19 Collaboration, Indian SARS-CoV-2 Genomics Consortium, Anurag Agarwal, Seiya Ozono, Kenzo Tokunaga, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato# & Ravindra K. Gupta#*. SARS-CoV-2 B.1.617 mutations L452R and E484Q are not synergistic for antibody evasion. Journal of Infectious Diseases 224(6):989-994, 2021. ‡Equal contribution; #Equal contribution.
  34. Chihiro Motozono, Mako Toyoda‡, Jiri Zahradnik‡, Akatsuki Saito‡, Hesham Nasser‡, Toong Seng Tan, Isaac Ngare, Izumi Kimura, Keiya Uriu, Yusuke Kosugi, Yuan Yue, Ryo Shimizu, Jumpei Ito, Shiho Torii, Akiko Yonekawa, Nobuyuki Shimono, Yoji Nagasaki, Rumi Minami, Takashi Toya, Noritaka Sekiya, Takasuke Fukuhara, Yoshiharu Matsuura, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Terumasa Ikeda*, So Nakagawa*, Takamasa Ueno* & Kei Sato*$. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host & Microbe 29(7):1124-1136, 2021. ‡Equal contribution; *Corresponding authors; $Lead contact. Selected to "Most Read" in Cell Host & Microbe.
  35. Keiya Uriu‡, Yusuke Kosugi‡, Narumi Suzuki‡, Jumpei Ito & Kei Sato*. Elucidation of the complicated scenario of primate APOBEC3 gene evolution. Journal of Virology 95(12):e00144-21, 2021. ‡Equal contribution; *Corresponding author.
  36. Yusuke Kosugi‡, Keiya Uriu‡, Narumi Suzuki‡, Keisuke Yamamoto‡, Shumpei Nagaoka‡, Izumi Kimura‡, Yoriyuki Konno‡, Hirofumi Aso‡, Brian Willett, Tomoko Kobayashi, Yoshio Koyanagi, Mahoko Takahashi Ueda, Jumpei Ito & Kei Sato*. Comprehensive investigation of the interplay between feline APOBEC3Z3 proteins and feline immunodeficiency virus Vif proteins. Journal of Virology 95(13):e00178-21, 2021. ‡Equal contribution; *Corresponding author. Selected to the cover of this issue in Journal of Virology.
  37. Izumi Kimura, Yoriyuki Konno, Keiya Uriu, Kristina Hopfensperger, Daniel Sauter, So Nakagawa & Kei Sato*. Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Reports 34(13):108916, 2021. *Corresponding author.
  38. Irwin Jungreisa*, Chase W. Nelson, Zachary Ardern, Yaara Finkel, Nevan J. Krogan, Kei Sato, John Ziebuhr, Noam Stern-Ginossar, Angelo Pavesi, Andrew E. Firth, Alexander E. Gorbalenya & Manolis Kellis. Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution. Virology 558, 145-151, 2021. Review.
  39. Keiya Uriu‡, Yusuke Kosugi‡, Jumpei Ito & Kei Sato*. The battle between viruses and APOBEC3 genes: its past and present. Viruses 13:124, 2021. ‡Equal contribution; *Corresponding author.
  40. Tomoki Inagaki‡, Yoshitaka Sato‡*, Jumpei Ito#, Mitsuaki Takaki#, Yusuka Okuno, Masahiro Yaguchi, H. M. Abdullah Al Masud, Takahiro Watanabe, Kei Sato, Shingo Iwami, Takayuki Murata & Hiroshi Kimura*. Direct evidence of abortive lytic infection-mediated establishment of Epstein-Barr virus latency during B-cell infection. Frontiers in Microbiology 11:575255, 2021. ‡Equal contribution; #Equal contribution.
  41. Andrew Soper, Yoshio Koyanagi & Kei Sato*. HIV-1 tracing method of systemic viremia in vivo using an artificially mutated virus pool. Microbiology and Immunology 65:17–27, 2021. *Corresponding author.
  42. Toshikazu Abe*, Terumasa Ikeda, Yasuharu Tokuda, Jumpei Ito, Yutaka Suzuki, Chisato Narahara, Hiroki Iriyama & Kei Sato. A patient infected with SARS-CoV-2 over 100 days. QJM: An International Journal of Medicine hcaa296, 2020.
  43. Young Sun Hwang‡, Shinnosuke Suzuki‡, Yasunari Seita‡, Jumpei Ito, Yuka Sakata, Hirofumi Aso, Kei Sato, Brian P Hermann & Kotaro Sasaki*. Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells. Nature Communications 11:5656, 2020. ‡Equal contribution.
  44. Jumpei Ito‡, Izumi Kimura‡, Andrew Soper, Alexandre Coudray, Yoshio Koyanagi, Hirofumi Nakaoka, Ituro Inoue, Priscilla Turelli, Didier Trono & Kei Sato*. Endogenous retroviruses drive KRAB zinc-finger protein family expression for tumor suppression. Science Advances 6(43):eabc3020, 2020. ‡Equal contribution; *Correspondence.
  45.               
  46. Yoriyuki Konno‡, Izumi Kimura‡, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, Daniel Sauter, Robert J. Gifford, USFQ-COVID19 Consortium, So Nakagawa & Kei Sato*. SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant. Cell Reports 32(12):108185, 2020. ‡Equal contribution; *Corresponding author. Selected to "Editor's pick" and "Most Read" in Cell Reports.
  47. Yusuke Nakano, Keisuke Yamamoto, Mahoko Takahashi Ueda, Andrew Soper, Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Ryuichi Kumata, Hirofumi Aso, Naoko Misawa, Shumpei Nagaoka, Soma Shimizu, Keito Mitsumune, Yusuke Kosugi, Guillermo Juarez-Fernandez, Jumpei Ito, So Nakagawa, Terumasa Ikeda, Yoshio Koyanagi, Reuben S Harris & Kei Sato*. A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans. PLOS Pathogens 16(9): e1008812, 2020. *Corresponding author.
  48. Misato Shibazaki‡, Akihisa Kato‡ Kosuke Takeshim, Jumpei Ito, Mai Suganami, Naoto Koyanagi, Yuhei Maruzuru, Kei Sato & Yasushi Kawaguchi*. Phospho-regulation of a conserved herpesvirus tegument protein by a virally-encoded protein kinase in viral pathogenicity and potential linkage between its evolution and viral phylogeny. Journal of Virology 94(18):e01055-20, 2020. ‡ Equal contribution.
  49. Xiaoxi Liu, Shunichi Kosugi, Rie Koide, Yoshiki Kawamura, Jumpei Ito, Hiroki Miura, Nana Matoba, Motomichi Matsuzaki, Masashi Fujita, Anselmo Jiro Kamada, Hidewaki Nakagawa, Gen Tamiya, Koichi Matsuda, Yoshinori Murakami, Michiaki Kubo, Amr Aswad, Kei Sato, Yukihide Momozawa, Jun Ohashi, Chikashi Terao, Tetsushi, Yoshikawa, Nicholas F. Parrish & Yoichiro Kamatani. Endogenization and excision of human herpesvirus 6 in human genomes. PLOS Genetics 16(8):e1008915, 2020.
  50. Hirofumi Aso‡, Shumpei Nagaoka‡, Eiryo Kawakami‡, Jumpei Ito, Saiful Islam, Benjy Jek Yang Tan, Shinji Nakaoka, Koichi Ashizaki, Katsuyuki Shiroguchi, Yutaka Suzuki, Yorifumi Satou, Yoshio Koyanagi & Kei Sato*. Multiomics investigation revealing the characteristics of HIV-1-infected cells in vivo. Cell Reports 32(2):107887, 2020. #Equal contribution; *correspondence.
  51. Ryuichi Kumata, Jumpei Ito, Kenta Takahashi, Tadaki Suzuki, & Kei Sato*. A tissue level atlas of the healthy human virome. BMC Biology doi: 10.1186/s12915-020-00785-5, 2020. *Corresponding author.
  52. Tatsuya Kurusu, Kwang Su Kim, Yoshiki Koizumi, Shinji Nakaoka, Keisuke Ejima, Naoko Misawa, Yoshio Koyanagi, Kei Sato* & Shingo Iwami*. Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model. Journal of Theoretical Biology 498:110295, 2020. *Corresponding authors.
  53. Ryuichi Kumata, Jumpei Ito & Kei Sato*. Inherited chromosomally integrated HHV-6 possibly modulates human gene expression. Virus Genes 56(3):386-389, 2020. *Corresponding author.
  54. Jumpei Ito, Robert J. Gifford, & Kei Sato*. Retroviruses drive the rapid evolution of mammalian APOBEC3 genes. Proceedings of the National Academy of Sciences of the United States of America 117(1):610-618, 2020. *Corresponding author.
  55. Masahide Yoshida, Yuki Takayanagi, Azusa Ichino-Yamashita, Kei Sato, Yukihiko Sugimoto, Tadashi Kimura, Katsuhiko Nishimori*. Functional hierarchy of uterotonics required for successful parturition in mice. Endocrinology 160(12):2800-2810, 2019.
  56. Daichi Yamasoba, Kei Sato, Takuya Ichinose, Tomoko Imamura, Lennart Koepke, Simone Joas, Elisabeth Reith, Dominik Hotter, Naoko Misawa, Kotaro Akaki, Takuya Uehata, Takashi Mino, Sho Miyamoto, Takeshi Noda, Akio Yamashita, Daron M. Standley, Frank Kirchhoff, Daniel Sauter, Yoshio Koyanagi and Osamu Takeuchi*. N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation. Nature Microbiology, 4:1532–1544, 2019.
  57. Hirofumi Aso, Jumpei Ito, Yoshio Koyanagi & Kei Sato*. Comparative description of the expression profile of interferon-stimulated genes in multiple cell lineages targeted by HIV-1 infection. Frontiers in Microbiology 10:429, 2019. *Corresponding author.
  58. Yoriyuki Konno, Shumpei Nagaoka, Izumi Kimura, Keisuke Yamamoto, Yumiko Kagawa, Ryuichi Kumata, Hirofumi Aso, Mahoko Takahashi Ueda, So Nakagawa, Tomoko Kobayashi, Yoshio Koyanagi & Kei Sato*. New World feline APOBEC3 potently controls inter-genus lentiviral transmission. Retrovirology 15(1):31, 2018. *Corresponding author.
  59. Yoriyuki Konno‡, Shumpei Nagaoka‡, Izumi Kimura‡, Mahoko Takahashi Ueda, Ryuichi Kumata, Jumpei Ito, So Nakagawa, Tomoko Kobayashi, Yoshio Koyanagi & Kei Sato*. A naturally occurring feline APOBEC3 variant that loses anti-lentiviral activity by lacking two amino acid residues. Journal of General Virology 99:704-709, 2018. *Corresponding author; ‡Equal contribution.
  60. Yohei Kurosaki‡, Mahoko Takahashi Ueda‡, Yusuke Nakano, Jiro Yasuda, Yoshio Koyanagi, Kei Sato & So Nakagawa. Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species. Journal of General Virology 99:181-186, 2018. ‡Equal contribution.
  61. Kei Sato*, Naoko Misawa, Junko S. Takeuchi, Tomoko Kobayashi, Taisuke Izumi, Hirofumi Aso, Shumpei Nagaoka, Keisuke Yamamoto, Izumi Kimura, Yoriyuki Konno, Yusuke Nakano & Yoshio Koyanagi. Experimental adaptive evolution of simian immunodeficiency virus SIVcpz to pandemic human immunodeficiency virus type 1 using a humanized mouse model. Journal of Virology 92(4):e01905-17, 2018. *Corresponding author.
  62. Andrew Soper, Izumi Kimura, Shumpei Nagaoka, Yoriyuki Konno, Keisuke Yamamoto, Yoshio Koyanagi & Kei Sato*. Type I interferon responses by HIV-1 infection: association with disease progression and control. Frontiers in Immunology 8:1823, 2018. *Correspondence.
  63. Eri Yamada, Shinji Nakaoka, Lukas Klein, Elisabeth Reith, Simon Langer, Kristina Hopfensperger, Shingo Iwami, Gideon Schreiber, Frank Kirchhoff, Yoshio Koyanagi, Daniel Sauter & Kei Sato*. Human-specific adaptations in Vpu conferring anti-tetherin activity are critical for efficient early HIV-1 replication in vivo. Cell Host & Microbe 23(1):110-120, 2018. *Correspondence. Introduced on the main page of Cell Host & Microbe.
  64. Ming Chen, Chie Aoki-Utsubo, Masanori Kameoka, Lin Deng, Yutaka Terada, Wataru Kamitani, Kei Sato, Yoshio Koyanagi, Makoto Hijikata, Keiko Shindo, Takeshi Noda, Michinori Kohara & Hak Hotta. Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane. Scientific Reports 7:15931, 2017.
  65. Yorifumi Satou‡*, Hiroo Katsuya‡, Asami Fukuda, Naoko Misawa, Jumpei Ito, Yoshikazu Uchiyama, Paola Miyazato, Mohammad S. Islam, Ariberto Fassati, Anat Melamed, Charles R. M. Bangham, Yoshio Koyanagi & Kei Sato. Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model. Scientific Reports 7:6913, 2017. ‡Equal contribution.
  66. Yusuke Nakano, Hirofumi Aso, Andrew Soper, Eri Yamada, Miyu Moriwaki, Guillermo Juarez-Fernandez, Yoshio Koyanagi & Kei Sato*. A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif. Retrovirology 14(1):31, 2017. Review. *Corresponding author.
  67. Yusuke Nakano, Naoko Misawa, Guillermo Juarez-Fernandez, Miyu Moriwaki, Shinji Nakaoka, Takaaki Funo, Eri Yamada, Andrew Soper, Rokusuke Yoshikawa, Diako Ebrahimi, Yuuya Tachiki, Shingo Iwami, Reuben S. Harris, Yoshio Koyanagi & Kei Sato*. HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation. PLOS Pathogens 13(5):e1006348, 2017. *Corresponding author. Introduced on the main page of PLOS Pathogens.
  68. Rokusuke Yoshikawa, Junko S. Takeuchi, Eri Yamada, Yusuke Nakano, Naoko Misawa, Yuichi Kimura, Fengrong Ren, Takayuki Miyazawa, Yoshio Koyanagi & Kei Sato*. Feline immunodeficiency virus evolutionarily acquires two proteins, Vif and protease, capable of antagonizing feline APOBEC3. Journal of Virology 91(11):e00250-17, 2017. *Corresponding author.
  69. Andrew Soper‡, Guillermo Juarez-Fernandez‡, Hirofumi Aso‡, Miyu Moriwaki, Eri Yamada, Yusuke Nakano, Yoshio Koyanagi & Kei Sato*. Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication. Experimental Biology and Medicine 242(8):850-858, 2017. Review. *Corresponding author; ‡Equal contribution.
  70. Mahoko Takahashi Ueda‡*, Yohei Kurosaki‡, Taisuke Izumi, Yusuke Nakano, Olamide K. Oloniniyi, Jiro Yasuda, Yoshio Koyanagi, Kei Sato* & So Nakagawa*. Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency. Genes to Cells 22(2):148-159, 2016. *Corresponding authors; ‡Equal contribution. 2017
  71. Alexey Martyushev, Shinji Nakaoka, Kei Sato, Takeshi Noda & Shingo Iwami. Modelling Ebola virus dynamics: implications for therapy. Antiviral Research 135:62-73, 2016.
  72. Eri Yamada, Rokusuke Yoshikawa, Yusuke Nakano, Naoko Misawa, Tomoko Kobayashi, Fengrong Ren, Taisuke Izumi, Takayuki Miyazawa, Yoshio Koyanagi & Kei Sato*. A naturally occurring bovine APOBEC3 confers resistance to bovine lentiviruses: implication for the co-evolution of bovids and their lentiviruses. Scientific Reports 6:33988, 2016. *Corresponding author.
  73. Belete A. Desimmie‡, Ryan C. Burdick‡, Taisuke Izumi‡, Hibiki Doi, Wei Shao, W. Gregory Alvord, Kei Sato, Yoshio Koyanagi, Sara Jones, Eleanor Wilson, Shawn Hill, Frank Maldarelli, Wei-Shau Hu & Vinay K. Pathak. APOBEC3 proteins can copackage and comutate HIV-1 genomes. Nucleic Acids Research 44(16):7848-7865, 2016. ‡Equal contribution.
  74. Zeli Zhang, Qinyong Gu, Ananda Ayyappan Jaguva Vasudevan, Anika Hain, Björn-Philipp Kloke, Sascha Hasheminasab, Daniel Mulnaes, Kei Sato, Klaus Cichutek, Dieter Häussinger, Ignacio G. Bravo, Sander H. J. Smits, Holger Gohlke & Carsten Münk. Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors. Retrovirology 13(1):46, 2016.
  75. Rokusuke Yoshikawa‡, Taisuke Izumi‡, Yusuke Nakano‡, Eri Yamada‡, Miyu Moriwaki, Naoko Misawa, Fengrong Ren, Tomoko Kobayashi, Yoshio Koyanagi & Kei Sato*. Small ruminant lentiviral Vif proteins commonly utilize cyclophilin A, an evolutionary and structurally conserved protein, to degrade ovine and caprine APOBEC3 proteins. Microbiology and Immunology 60(6):427-436, 2016. *‡Equal contribution; *Corresponding author.
  76. Hiroki Ikeda, Shinji Nakaoka, Rob J. de Boer, Satoru Morita, Naoko Misawa, Yoshio Koyanagi, Kazuyuki Aihara, Kei Sato* & Shingo Iwami*. Quantifying the effect of Vpu on the promotion of HIV-1 replication in the humanized mouse model. Retrovirology 13:23, 2016. *Corresponding authors.
  77. Rokusuke Yoshikawa, Yusuke Nakano, Eri Yamada, Taisuke Izumi, Naoko Misawa, Yoshio Koyanagi & Kei Sato*. Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins. Microbiology and Immunology 60(4):272-279, 2016. *Corresponding author.
  78. Rokusuke Yoshikawa, Taisuke Izumi, Eri Yamada, Yusuke Nakano, Naoko Misawa, Fengrong Ren, Michael A. Carpenter, Terumasa Ikeda, Carsten Münk, Reuben S. Harris, Takayuki Miyazawa, Yoshio Koyanagi & Kei Sato*. A naturally occurring domestic cat APOBEC3 variant confers resistance to FIV infection. Journal of Virology 90(1):474-485, 2015. *Corresponding author.
  79. Junko S. Takeuchi‡, Fengrong Ren‡, Rokusuke Yoshikawa‡, Eri Yamada, Yusuke Nakano, Tomoko Kobayashi, Kenta Matsuda, Taisuke Izumi, Naoko Misawa, Yuta Shintaku, Katherine S. Wetzel, Ronald G. Collman, Hiroshi Tanaka, Vanessa M. Hirsch, Yoshio Koyanagi & Kei Sato*. Coevolutionary dynamics between tribe Cercopithecini tetherins and their lentiviruses. Scientific Reports 5:16021, 2015. ‡Equal contribution; *Corresponding author.
  80. Shinji Nakaoka, Shingo Iwami & Kei Sato. Dynamics of HIV infection in lymphoid tissue network. Journal of Mathematical Biology 72(4):909-938, 2016.
  81. Shingo Iwami‡*, Junko S. Takeuchi‡, Shinji Nakaoka, Fabrizio Mammano, François Clavel, Hisashi Inaba, Tomoko Kobayashi, Naoko Misawa, Kazuyuki Aihara, Yoshio Koyanagi & Kei Sato*. Cell-to-cell infection by HIV contributes over half of virus infection. eLife 4:e08150, 2015. ‡Equal contribution; *Corresponding authors.
  82. Kei Sato*, Tomoko Kobayashi, Naoko Misawa, Rokusuke Yoshikawa, Junko S. Takeuchi, Tomoyuki Miura, Munehiro Okamoto, Jun-ichirou Yasunaga, Masao Matsuoka, Mamoru Ito, Takayuki Miyazawa & Yoshio Koyanagi. Experimental evaluation of the zoonotic infection potency of simian retrovirus type 4 using humanized mouse model. Scientific Reports 5:14040, 2015. *Corresponding author.
  83. Shingo Iwami‡*, Kei Sato‡*, Satoru Morita, Hisashi Inaba, Tomoko Kobayashi, Junko S. Takeuchi, Yuichi Kimura, Naoko Misawa, Fengrong Ren, Yoh Iwasa, Kazuyuki Aihara & Yoshio Koyanagi. Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin. Scientific Reports 5:12256, 2015. ‡Equal contribution; *Corresponding authors.
  84. Yusuke Nakano, Kenta Matsuda, Rokusuke Yoshikawa, Eri Yamada, Naoko Misawa, Vanessa M. Hirsch, Yoshio Koyanagi & Kei Sato*. Down-modulation of primate lentiviral receptors by Nef proteins of simian immunodeficiency virus (SIV) of chimpanzees (SIVcpz) and related SIVs: implication for the evolutionary event at the emergence of SIVcpz. Journal of General Virology 96(9):2867-2877, 2015. *Corresponding author.
  85. Yusuke Kakizoe, Satoru Morita, Shinji Nakaoka, Yasuhiro Takeuchi, Kei Sato, Tomoyuki Miura, Catherine A. Beauchemin & Shingo Iwami. A conservation law for virus infection kinetics in vitro. Journal of Theoretical Biology 376:39-47, 2015.
  86. Eri Yamada, Rokusuke Yoshikawa, Yusuke Nakano, Naoko Misawa, Yoshio Koyanagi & Kei Sato*. Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo. Viruses 7:1373-1390, 2015. Review. *Corresponding author.
  87. Rokusuke Yoshikawa‡, Junko S. Takeuchi‡, Eri Yamada, Yusuke Nakano, Fengrong Ren, Hiroshi Tanaka, Carsten Münk, Reuben S. Harris, Takayuki Miyazawa, Yoshio Koyanagi & Kei Sato*. Vif determines the requirement for CBF-β in APOBEC3 degradation. Journal of General Virology 96:887-892, 2015. ‡Equal contribution; *Corresponding author.
  88. Hiroki Ikeda, Shinji Nakaoka, Kei Sato, Naoko Misawa, Yoshio Koyanagi & Shingo Iwami*. Effect of eclipse phase on quantifying viral dynamics of acute HIV-1 infection in humanized mouse model. Nonlinear Theory and Its Applications, IEICE 6(1):47-53, 2015.
  89. Kei Sato‡*, Junko S. Takeuchi‡, Naoko Misawa, Taisuke Izumi, Tomoko Kobayashi, Yuichi Kimura, Shingo Iwami, Akifumi Takaori-Kondo, Wei-Shau Hu, Kazuyuki Aihara, Mamoru Ito, Dong Sung An, Vinay K. Pathak & Yoshio Koyanagi. APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model. PLOS Pathogens 10(10):e1004453, 2014. ‡Equal contribution; *Corresponding author.
  90. Tomoko Kobayashi‡, Junko S. Takeuchi‡, Fengrong Ren‡, Kenta Matsuda‡, Kei Sato‡*, Yuichi Kimura, Naoko Misawa, Rokusuke Yoshikawa, Yusuke Nakano, Eri Yamada, Hiroshi Tanaka, Vanessa M. Hirsch & Yoshio Koyanagi. Characterization of red-capped mangabey tetherin: implication for the co-evolution of primates and their lentiviruses. Scientific Reports 4:5529, 2014. ‡Equal contribution; *Corresponding author.
  91. Hiroki Ikeda, Rob J. de Boer, Kei Sato, Satoru Morita, Naoko Misawa, Yoshio Koyanagi, Kazuyuki Aihara & Shingo Iwami*. Improving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model. Theoretical Biology and Medical Modelling 11:22, 2014.
  92. Tomoko Kobayashi‡, Junko S. Takeuchi‡, Fengrong Ren‡, Kenta Matsuda‡, Kei Sato‡*, Yuichi Kimura, Naoko Misawa, Rokusuke Yoshikawa, Yusuke Nakano, Eri Yamada, Hiroshi Tanaka, Vanessa M. Hirsch & Yoshio Koyanagi. Characterization of red-capped mangabey tetherin: implication for the co-evolution of primates and their lentiviruses. Scientific Reports 4:5529, 2014. ‡Equal contribution; *Corresponding author.
  93. Mayumi Imahashi, Taisuke Izumi, Dai Watanabe, Junji Imamura, Kazuhiro Matsuoka, Hirotaka Ode, Takashi Masaoka, Kei Sato, Noriyo Kaneko, Seiichi Ichikawa, Yoshio Koyanagi, Akifumi Takaori-Kondo, Makoto Utsumi, Yoshiyuki Yokomaku, Takuma Shirasaka, Wataru Sugiura, Yasumasa Iwatani* & Tomoki Naoe. Lack of association between Intact/Deletion polymorphisms of the APOBEC3B gene and HIV-1 risk. PLOS ONE 9(3):e92861, 2014.
  94. Kei Sato*, Naoko Misawa, Shingo Iwami, Yorifumi Satou, Masao Matsuoka, Yukihito Ishizaka, Mamoru Ito, Kazuyuki Aihara, Dong Sung An & Yoshio Koyanagi*. HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo. PLOS Pathogens 9(12):e1003812, 2013. *Corresponding author. Selected to “featured research” in PLOS Pathogens. Introduced in “research highlights”, Nature Immunology, 15(2):142, 2014.
  95. Mitsuko Fukuhara‡, Shingo Iwami‡*, Kei Sato‡*, Yorihiro Nishimura, Hiroyuki Shimizu, Kazuyuki Aihara & Yoshio Koyanagi. Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation. Journal of Virology 87(1):701-705, 2013. ‡Equal contribution; *Corresponding authors.
  96. Shingo Iwami*, Kei Sato, Rob J. de Boer, Kazuyuki Aihara, Tomoyuki Miura & Yoshio Koyanagi. Identifying viral parameters from in vitro cell cultures. Frontiers in Microbiology 3:319, 2012.
  97. Kei Sato*, Peter Gee & Yoshio Koyanagi*. Vpu and BST2: still not there yet? Frontiers in Microbiology 3:131, 2012. Review. *Corresponding authors.
  98. Shingo Iwami*, Benjamin P. Holder, Catherine A. A. Beauchemin, Satoru Morita, Tetsuko Tada, Kei Sato, Tatsuhiko Igarashi & Tomoyuki Miura*. Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model. Retrovirology 9(1):18, 2012. Nominated to “highly accessed article” in RetroVirology.
  99. Kei Sato, Naoko Misawa, Mitsuko Fukuhara, Shingo Iwami, Dong Sung An, Mamoru Ito & Yoshio Koyanagi*. Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. Journal of Virology 86(9):5000-5013, 2012.
  100. Tadashi Watanabe, Emiko Urano, Kosuke Miyauchi, Reiko Ichikawa, Makiko Hamatake, Naoko Misawa, Kei Sato, Hirotaka Ebina, Yoshio Koyanagi & Jun Komano*. The hematopoietic cell-specific Rho GTPase inhibitor ARHGDIB/D4GDI limits HIV type 1 replication. AIDS Research and Human Retroviruses 28(8):913-922, 2011.
  101. Kei Sato* & Yoshio Koyanagi*. The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models. Experimental Biology and Medicine 236(8):977-985, 2011. Review. *Corresponding authors.
  102. Kei Sato, Naoko Misawa, Chuanyi Nie, Yorifumi Satou, Dai Iwakiri, Masao Matsuoka, Rei Takahashi, Kiyotaka Kuzushima, Mamoru Ito, Kenzo Takada & Yoshio Koyanagi*. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 117(21):5663-5673, 2011.
  103. Tomoko Kobayashi, Hirotaka Ode, Takeshi Yoshida, Kei Sato, Peter Gee, Seiji P. Yamamoto, Hirotaka Ebina, Klaus Strebel, Hironori Sato & Yoshio Koyanagi*. Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. Journal of Virology 85(2):932-945, 2011.
  104. Kei Sato, Taisuke Izumi, Naoko Misawa, Tomoko Kobayashi, Yoshiki Yamashita, Masahide Ohmichi, Mamoru Ito, Akifumi Takaori-Kondo & Yoshio Koyanagi*. Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. Journal of Virology 84(18):9546-9556, 2010.
  105. Kei Sato‡, Chuanyi Nie‡, Naoko Misawa‡, Yuetsu Tanaka, Mamoru Ito & Yoshio Koyanagi. Dynamics of memory and naive CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rγnull mice infected with CCR5-tropic HIV-1. Vaccine 28S2:B32-37, 2010. ‡Equal contribution.
  106. Chuanyi Nie‡, Kei Sato‡, Naoko Misawa, Hiroko Kitayama, Hisanori Fujino, Hidefumi Hiramatsu, Toshio Heike, Tatsutoshi Nakahata, Yuetsu Tanaka, Mamoru Ito & Yoshio Koyanagi. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rγnull mice. Virology 394:64-72, 2009. ‡Equal contribution.
  107. Kei Sato, Seiji P. Yamamoto, Naoko Misawa, Takeshi Yoshida, Takayuki Miyazawa & Yoshio Koyanagi*. Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Retrovirology 6:53, 2009. Nominated to “highly accessed article” in Retrovirology.
  108. Takeshi Yoshida, Yuji Kawano, Kei Sato, Yoshinori Ando, Jun Aoki, Yoshiharu Miura, Jun Komano, Yuetsu Tanaka & Yoshio Koyanagi. A CD63 mutant inhibits T-cell tropic human immunodeficiency virus type 1 entry by disrupting CXCR4 Trafficking to the plasma membrane. Traffic 9:540-558, 2008.
  109. Kei Sato, Jun Aoki, Naoko Misawa, Eriko Daikoku, Kouichi Sano, Yuetsu Tanaka & Yoshio Koyanagi*. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. Journal of Virology 82(2):1021-1033,2008.
  110. Kei Sato*. Host factor-mediated resistance to HIV-1 infection. Humanized Mice for HIV Research (eds Poluektova L, Garcia-Martinez V, Koyanagi Y, Münz M, and Tager A) pp.223-234, Springer, 2014. *Correspondence.

日本語総説など

  1. 佐藤佳, 小柳義夫. HIV感染症とAIDSの発症原理. Virus Report, 医療ジャーナル社, 3巻2号, pp. 24-31, 2006.(商業誌)
  2. 佐藤佳, 小柳義夫. Sputnik Sweetheart–ウイルスに感染するウイルス. ウイルス, 58巻2号, pp. 219-220, 2008.(日本ウイルス学会誌)
  3. 佐藤佳, 小柳義夫. HIV-1のウイルス-宿主相互作用と新規治療薬の開発. 実験医学, 羊土社, 28巻18号, pp. 2961-2918, 2010.(商業誌)
  4. 佐藤佳, 小柳義夫. ヒト化マウスの利用:EBウイルス関連血球貪食性リンパ球組織球症動物モデル. 血液内科, 科学評論社, 63巻6号, pp. 627-633, 2011.(商業誌)
  5. 佐藤佳. ヒト化マウスモデルを用いたHIV-1タンパク質の機能解明. 日本エイズ学会誌, 15巻2号, pp. 96-101, 2013.(日本エイズ学会誌
  6. 佐藤佳. Cold Spring Harbor Laboratory Meeting on Retroviruses 2013. 日本エイズ学会誌, 15巻3号, pp. 206-208, 2013.(日本エイズ学会誌
  7. 岩見真吾, 佐藤佳, 合原一幸, 波江野洋, 錦織桃子, 高折晃史, 小柳義夫. 細胞のダイナミクスを記述する. 科学, 岩波書店, 83巻20号, pp. 1184-1189, 2013.(商業誌)
  8. 佐藤佳, 小柳義夫. HIV-1のウイルス学. HIV感染症とAIDS 改定第2版(満屋裕明 編), 最新医学社, 第2章, pp. 32-38, 2014.(商業誌)
  9. 佐藤佳. HIV-1アクセサリー蛋白質および宿主防御因子のヒト化マウスモデルによる評価. 日本エイズ学会誌, 17巻2号, pp. 67-70, 2015.(日本エイズ学会誌
  10. 佐藤佳. ヒト化マウスモデルを用いたウイルス感染病態の解明. ウイルス, 66巻1号, pp. 91-100, 2016.(日本ウイルス学会誌)
  11. 佐藤佳, 小柳義夫. HIV-1とAPOBECのせめぎ合い. 生化学, 88巻5号, pp. 569-575, 2016.(日本生化学会誌)
  12. 佐藤佳, 小柳義夫. AIDSウイルスとヒトの進化的軍拡競争 ― ウイルス蛋白質とヒト蛋白質の相互作用からみえてくる進化的せめぎあい. 医学のあゆみ, 260巻6号, pp. 17037-17041, 2017.(商業誌)
  13. 岩見真吾, 佐藤佳. ウイルス感染の数理科学的理解. 実験医学増刊 生命科学で使えるはじめての数理モデルとシミュレーション(鈴木貴, 久保田浩行 編), 羊土社, 35巻5号, pp. 883-886, 2017.(商業誌)
  14. 佐藤佳. ヒト特異的ウイルス感染症のモデルとしてのヒト化マウス. 臨床免疫・アレルギー科, 科学評論社, 68巻3号, pp. 255-262, 2017.(商業誌)
  15. 佐藤佳. 公的データベースとバイオインフォマティクスを基盤としたウイルス感染症の理解. 医学のあゆみ, 科学評論社, 263巻2号, pp. 188-189, 2017.(商業誌)
  16. 佐藤佳. HIV-1と免疫のせめぎあい:進化の原理と初期感染における攻防.医学のあゆみ, 267巻4号, pp. 301-303, 2018.(商業誌)

日本語著書など

  1. 岩見真吾, 佐藤佳, 竹内康博. ウイルス感染と常微分方程式(シリーズ・現象を解明する数学; 三村昌泰, 竹内康博, 森田善久 編). 共立出版, 2017.